A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Treanda (bendamustine HCL): Recall – Particulate Matter in Vial. According to the Food & Drug Administration FDA’s MedWatch:
Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Treanda (bendamustine HCL): Recall – Particulate Matter in Vial.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.